Drug Database
TI

tinazoline (Varsyl / tinazoline)

✓ Approved

Novartis AG · Small Molecule · Small Molecule

What is tinazoline?

tinazoline is a small molecule developed by Novartis AG. It is approved for therapeutic indications.

Drug Profile

Brand NamesVarsyl, tinazoline
CompanyNovartis AG
Drug ClassSmall Molecule
StatusApproved
Sources: ClinicalTrials.gov, Novartis AG

Therapeutic Indications

tinazoline is developed for 2 unique indications across 2 therapeutic areas.

Therapeutic AreaConditionPhase
Cardiac disordersCardiovascular disorder✓ Approved
Immune system disordersHypersensitivity✓ Approved

Related Research Articles

PubMedJournal of postgraduate medicine1983-07-01

Tolerability profile of a new nasal decongestant--tinazoline hydrochloride (Go-7996 B): open and double-blind studies in human male volunteers.

Vaidya A B AB, Paul T T, Talwalkar S S, Mankodi N A NA et al.

PMID 6197522
Read full article →
PubMedIndian journal of experimental biology1981-12-01

Structure activity relations among cyclic acyclic S-(3-indolyl) isothioureas-development of a potent vasoconstrictor, tinazoline, 3-(2-imidazolin-2-yl-thio)indole.

Nagarajan K K, Arya V P VP, Kaul C L CL, David J J et al.

PMID 7333649
Read full article →

Ask about tinazoline